Quintiles has been named Best Clinical Research Organization in the Vaccine Industry Excellence (ViE) Awards 2012, presented at the World Vaccine Congress in Washington, D.C. The award recognizes the leaders, innovators and pioneers in the vaccines industry. “This is a great honor to be recognized as the Best CRO at the World Vaccine Congress,” said Dr. Ellen Vigdorth, vice president of Allergy, Respiratory, Infectious Diseases and Vaccines. “It is a huge achievement and underscores our commitment to the development of quality vaccines and anti-infective products.
Customers voted for their preferred CRO and a judging panel made its selection based on the following criteria: range of services provided in niche and core therapeutic areas; methods of performance improvement or introduction of new services; attention to and quality of relationships with clients; reaching of milestones and final/ongoing outcomes; and building and maintaining existing and long-term partnerships.
Quintiles Named Best CRO In Vaccine Excellence
Published April 13, 2012
blog comments powered by Disqus